BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7585847)

  • 21. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
    Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
    Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative study of the speed of acid-suppressing effects of oral administration of cimetidine and famotidine.
    Adachi K; Komazawa Y; Mihara T; Azumi T; Fujisawa T; Katsube T; Furuta K; Kinoshita Y
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1012-5. PubMed ID: 15955208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intravenous cimetidine or two regimens of ranitidine to reduce fasting gastric acidity.
    Peterson WL; Richardson CT
    Ann Intern Med; 1986 Apr; 104(4):505-7. PubMed ID: 3954278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamics and pharmacokinetics of parenteral histamine (H2)-receptor antagonists.
    Ostro MJ
    Am J Med; 1987 Dec; 83(6A):15-22. PubMed ID: 2892405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative pharmacodynamics and pharmacokinetics of cimetidine and ranitidine.
    Richards DA
    J Clin Gastroenterol; 1983; 5 Suppl 1():81-90. PubMed ID: 6317740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of famotidine with cimetidine and ranitidine.
    Berardi RR; Tankanow RM; Nostrant TT
    Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intragastric pH monitoring in acute upper gastrointestinal bleeding and the effect of intravenous cimetidine and ranitidine.
    Reynolds JR; Walt RP; Clark AG; Hardcastle JD; Langman MJ
    Aliment Pharmacol Ther; 1987 Feb; 1(1):23-30. PubMed ID: 2979209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-dose famotidine and ranitidine as single post-prandial doses: a three-period placebo-controlled comparative trial.
    Reilly TG; Singh S; Cottrell J; Mann SG; Stauffer L; Walt RP
    Aliment Pharmacol Ther; 1996 Oct; 10(5):749-55. PubMed ID: 8899083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative trial of the effect of ranitidine and cimetidine on gastric secretion in fasting patients at induction of anaesthesia.
    Durrant JM; Strunin L
    Can Anaesth Soc J; 1982 Sep; 29(5):446-51. PubMed ID: 6127150
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative efficacy of parenteral histamine (H2)-antagonists in acid suppression for the prevention of stress ulceration.
    Critchlow JF
    Am J Med; 1987 Dec; 83(6A):23-8. PubMed ID: 2892406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
    Fullarton GM; Macdonald AM; McColl KE
    Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of various histamine H2-receptor antagonists on gastrointestinal motility and gastric emptying].
    Ohira Y; Hanyu N; Aoki T; Hashimoto Y; Iikura M; Fukuda S
    J Smooth Muscle Res; 1993 Aug; 29(4):131-42. PubMed ID: 7907895
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of H2-receptor antagonists on gastric alcohol dehydrogenase activity.
    Caballería J; Baraona E; Deulofeu R; Hernández-Muñoz R; Rodés J; Lieber CS
    Dig Dis Sci; 1991 Dec; 36(12):1673-9. PubMed ID: 1684149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Gastric acid secretion and histamine H2 receptor antagonists].
    Gespach C; Emami S; Di Gioia Y; Chastre E
    Gastroenterol Clin Biol; 1990; 14(12):982-94. PubMed ID: 1981198
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of ranitidine and of cimetidine on pentagastrin-stimulated gastric acid secretion.
    Holloway RH; Kuljian B; Eshelman F; McCallum RW
    Clin Pharmacol Ther; 1984 Feb; 35(2):203-7. PubMed ID: 6319068
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine.
    Hamilton MI; Sercombe J; Pounder RE
    Aliment Pharmacol Ther; 2001 Oct; 15(10):1579-83. PubMed ID: 11563997
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
    Ohsawa T; Hirata W; Higichi S
    Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Statistical interpretation of the antisecretory effect of famotidine measured by intragastric pH-metry.
    Hunyady B; Juricskay I; Nagy L; Garamszegi M; Vincze A; Mózsik G
    Eur J Clin Pharmacol; 1996; 50(6):449-56. PubMed ID: 8858270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells.
    Hahm KB; Park IS; Kim HC; Lee KJ; Kim JH; Cho SW; Lee SI
    Int J Immunopharmacol; 1996; 18(6-7):393-9. PubMed ID: 9024941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.